These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15286106)

  • 1. Enamel matrix derivative for periodontal tissue regeneration in treatment of intrabony defects: a Cochrane systematic review.
    Esposito M; Coulthard P; Thomsen P; Worthington HV
    J Dent Educ; 2004 Aug; 68(8):834-44. PubMed ID: 15286106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2003; (2):CD003875. PubMed ID: 12804493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Grusovin MG; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003875. PubMed ID: 16235343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD003875. PubMed ID: 19821315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
    Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
    J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does enamel matrix derivative application provide additional clinical benefits in residual periodontal pockets associated with suprabony defects? A systematic review and meta-analysis of randomized clinical trials.
    Graziani F; Gennai S; Cei S; Ducci F; Discepoli N; Carmignani A; Tonetti M
    J Clin Periodontol; 2014 Apr; 41(4):377-86. PubMed ID: 24329867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.
    Li W; Xiao L; Hu J
    J Am Dent Assoc; 2012 Sep; 143(9):e46-56. PubMed ID: 22942155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical guidelines of the Italian Society of Periodontology for the reconstructive surgical treatment of angular bony defects in periodontal patients.
    Pagliaro U; Nieri M; Rotundo R; Cairo F; Carnevale G; Esposito M; Cortellini P; Pini-Prato G;
    J Periodontol; 2008 Dec; 79(12):2219-32. PubMed ID: 19053910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of a resorbable bone substitute with a resorbable membrane in the treatment of periodontal infrabony defect - A multicenter randomised controlled trial.
    Esposito M; Grusovin MG; Lambert F; Matos S; Pietruska M; Rossi R; Salhi L; Buti J
    Eur J Oral Implantol; 2015; 8(3):233-44. PubMed ID: 26355168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effectiveness of enamel matrix derivative, bone grafts, and membrane in the treatment of mandibular Class II furcation defects.
    Jaiswal R; Deo V
    Int J Periodontics Restorative Dent; 2013; 33(2):e58-64. PubMed ID: 23484181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guided tissue regeneration for periodontal infra-bony defects.
    Needleman IG; Worthington HV; Giedrys-Leeper E; Tucker RJ
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001724. PubMed ID: 16625546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous platelet concentrates for treating periodontal infrabony defects.
    Del Fabbro M; Karanxha L; Panda S; Bucchi C; Nadathur Doraiswamy J; Sankari M; Ramamoorthi S; Varghese S; Taschieri S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011423. PubMed ID: 30484284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.